Literature DB >> 28396528

Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four Donors.

Ming-Chih David Ho1, Nicholas Ring1, Kirsten Amaral1, Utkarsh Doshi1, Albert P Li2.   

Abstract

We report in this work successful isolation and cryopreservation of enterocytes from human small intestine. The enterocytes were isolated by enzyme digestion of the intestinal lumen, followed by partial purification via differential centrifugation. The enterocytes were cryopreserved directly after isolation without culturing to maximize retention of in vivo drug-metabolizing enzyme activities. Post-thaw viability of the cryopreserved enterocytes was consistently over 80% based on trypan blue exclusion. Cryopreserved enterocytes pooled from eight donors (four male and four female) were evaluated for their metabolism of 14 pathway-selective substrates: CYP1A2 (phenacetin hydroxylation), CYP2A6 (coumarin 7-hydroxylation), CYP2B6 (bupropion hydroxylation), CYP2C8 (paclitaxel 6α-hydroxylation), CYP2C9 (diclofenac 4-hydroxylation), CYP2C19 (S-mephenytoin 4-hydroxylation), CYP2D6 (dextromethorphan hydroxylation), CYP2E1 (chlorzoxazone 6-hydroxylation), CYP3A4 (midazolam 1'-hydroxylation and testosterone 6β-hydroxylation), CYP2J2 (astemizole O-demethylation), UDP-glucuronosyltransferase (UGT; 7-hydroxycoumarin glucuronidation), sulfotransferase (SULT; 7-hydroxycoumarin sulfation), and carboxylesterase 2 (CES2; irinotecan hydrolysis) activities. Quantifiable activities were observed for CYP2C8, CYP2C9, CYP2C19, CYP2E1, CYP3A4, CYPJ2, CES2, UGT, and SULT, but not for CYP1A2, CYP2A6, CYP2B6, and CYP2D6. Enterocytes from all 24 donors were then individually evaluated for the quantifiable drug metabolism pathways. All demonstrated quantifiable activities with the expected individual variations. Our results suggest that cryopreserved human enterocytes represent a physiologically relevant and convenient in vitro experimental system for the evaluation of intestinal metabolism, akin to cryopreserved human hepatocytes for hepatic metabolism.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Year:  2017        PMID: 28396528     DOI: 10.1124/dmd.116.074377

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  13 in total

Review 1.  Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.

Authors:  Marilyn N Martinez; Jonathan P Mochel; Sibylle Neuhoff; Devendra Pade
Journal:  AAPS J       Date:  2021-04-27       Impact factor: 4.009

2.  Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.

Authors:  Haeyoung Zhang; Abdul Basit; Diana Busch; King Yabut; Deepak Kumar Bhatt; Marek Drozdzik; Marek Ostrowski; Albert Li; Carol Collins; Stefan Oswald; Bhagwat Prasad
Journal:  Biochem Pharmacol       Date:  2018-08-04       Impact factor: 5.858

3.  In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP-glucuronosyltransferase enzymes by ultra high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.

Authors:  Jinjin Xu; Mengsen Li; Zhihong Yao; Yezi Zhang; Shishi Li; Liufang Hu; Zifei Qin; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Biomed Anal       Date:  2018-06-18       Impact factor: 3.935

Review 4.  Gutsy science: In vitro systems of the human intestine to model oral drug disposition.

Authors:  Christopher M Arian; Tomoki Imaoka; Jade Yang; Edward J Kelly; Kenneth E Thummel
Journal:  Pharmacol Ther       Date:  2021-08-31       Impact factor: 12.310

Review 5.  Emerging Role of Organ-on-a-Chip Technologies in Quantitative Clinical Pharmacology Evaluation.

Authors:  Nina Isoherranen; Rajanikanth Madabushi; Shiew-Mei Huang
Journal:  Clin Transl Sci       Date:  2019-03       Impact factor: 4.689

6.  Listeria monocytogenes cell-to-cell spread in epithelia is heterogeneous and dominated by rare pioneer bacteria.

Authors:  Fabian E Ortega; Elena F Koslover; Julie A Theriot
Journal:  Elife       Date:  2019-02-05       Impact factor: 8.140

7.  A Novel In vitro Experimental System for the Evaluation of Enteric Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Enterocytes (MetMax™ Cryopreserved Human Enterocytes).

Authors:  Albert P Li; Kirsten Amaral; Ming-Chih D Ho
Journal:  Drug Metab Lett       Date:  2018

8.  Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.

Authors:  Jennifer E Speer; Yuli Wang; John K Fallon; Philip C Smith; Nancy L Allbritton
Journal:  J Biol Eng       Date:  2019-11-04       Impact factor: 4.355

Review 9.  3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.

Authors:  Hongbing Wang; Paul C Brown; Edwin C Y Chow; Lorna Ewart; Stephen S Ferguson; Suzanne Fitzpatrick; Benjamin S Freedman; Grace L Guo; William Hedrich; Scott Heyward; James Hickman; Nina Isoherranen; Albert P Li; Qi Liu; Shannon M Mumenthaler; James Polli; William R Proctor; Alexandre Ribeiro; Jian-Ying Wang; Ronald L Wange; Shiew-Mei Huang
Journal:  Clin Transl Sci       Date:  2021-06-16       Impact factor: 4.438

10.  Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.

Authors:  Albert P Li; Ming-Chih D Ho; Novera Alam; Walter Mitchell; Susan Wong; Zhengyin Yan; Jane R Kenny; Cornelis E C A Hop
Journal:  Pharmacol Res Perspect       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.